These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4006810)

  • 21. [Measles vaccination in the Sudan-Sahel region of Africa. Absence of the immunodepressive effect of malaria].
    Monjour L; Bourdillon F; Froment A; Daniel-Ribeiro C; Tirard S; Datry A; Chastang C; Tselentis Y; Gentilini M
    Pathol Biol (Paris); 1985 Apr; 33(4):232-5. PubMed ID: 3892451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
    de Haas PW; Masurel N; Anker WJ
    Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 25. [An investigation of the sero-epidemiological effect of emergent vaccination with measles vaccine].
    Zhang RZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1987 Oct; 8(5):288-90. PubMed ID: 3449217
    [No Abstract]   [Full Text] [Related]  

  • 26. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 27. [Post-vaccination measles immunity in children on long-term anticonvulsant therapy].
    Popović-Miocinović L; Smerdel S; Grubesić Z; Miklousić A
    Lijec Vjesn; 1994; 116(3-4):74-8. PubMed ID: 8057741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of neutralizing antibodies against measles virus in Indians of Xingu, Central Brazil].
    Baruzzj RG; Rodrigues MC; Carvalho RP; de Souza-Dias LC
    Rev Inst Med Trop Sao Paulo; 1971; 13(5):356-62. PubMed ID: 5162259
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 30. [Status of immunization against measles in the pediatric population of the province of Ferrara].
    Bezzi TM; Soriani S; Trombini R; Scorrano M
    Minerva Pediatr; 1980 Apr; 32(8):581. PubMed ID: 7393191
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiment of vaccination against measles using attenuated virus (Schwarz strain) (author's transl)].
    Trivello R; Renzulli G; Romano M; Milone G; Moschen ME
    Ann Sclavo; 1978; 20(2):113-20. PubMed ID: 742926
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles (rubeola) in previously immunized children.
    Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
    Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.